# OnCo record paper-nct03476681-j-exp-clin-cancer-res-2023 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-nct03476681-j-exp-clin-cancer-res-2023/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-nct03476681-j-exp-clin-cancer-res-2023" ;
  schema:name "First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors"@en ;
  schema:description "Published report from the trial registered as NCT03476681, in Journal of experimental & clinical cancer research (2023), chosen as the most cited paper whose own text cites the registry id."@en ;
  schema:url <https://onco.cc/key-papers/paper-nct03476681-j-exp-clin-cancer-res-2023/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1186/s13046-023-02649-6>, <https://pubmed.ncbi.nlm.nih.gov/36991390/>, <https://europepmc.org/article/MED/36991390>, <https://clinicaltrials.gov/study/NCT03476681> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1186/s13046-023-02649-6> ;
  schema:datePublished "2023"^^xsd:gYear ;
  schema:author "Cole CB, Morelli MP, Fantini M, et al." ;
  onco:trials <https://onco.cc/trials/nct03476681/> ;
  onco:journals <https://onco.cc/journals/journal-of-experimental-and-clinical-cancer-research/> .